These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4957918)

  • 21. Correlation between the detection of specific mouse mammary tumor proviral sequences and the presence of pulmonary metastases in mice bearing spontaneous mammary tumors.
    Drohan W; Cardiff RD; Lund JK; Schlom J
    Cancer Res; 1980 Jul; 40(7):2316-22. PubMed ID: 6248203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of levamisole on the incidence of spontaneous mammary tumors in C3H mice.
    Page RH; Valdivia DA; Talley RW; Huseby RA
    Henry Ford Hosp Med J; 1982; 30(2):65-9. PubMed ID: 7129945
    [No Abstract]   [Full Text] [Related]  

  • 23. [Expression of Thy 1 thymocyte differentiation antigen in mouse mammary cancer cells in vitro].
    Kriukova IN; Litvinov SV
    Biull Eksp Biol Med; 1983 Aug; 96(8):81-4. PubMed ID: 6411148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigens on naturally occurring animal and human tumors detected by monoclonal antibodies.
    Embleton MJ; Gunn B; Byers VS; Baldwin RW
    Transplant Proc; 1981 Dec; 13(4):1966-9. PubMed ID: 6949387
    [No Abstract]   [Full Text] [Related]  

  • 25. Circulating immune complexes, antigens, and antibodies related to the murine mammary tumor virus in C3H mice.
    Dong ZW; Witkin SS; Fernandes G; Sarkar NH; Good RA; Day NK
    J Immunol; 1982 Aug; 129(2):872-6. PubMed ID: 6282972
    [No Abstract]   [Full Text] [Related]  

  • 26. Lack of Thy 1.2 antigen expression on the surfaces of mouse mammary epithelial cells.
    Thompson K
    J Natl Cancer Inst; 1981 Jul; 67(1):143-8. PubMed ID: 6265679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunology of the mouse mammary tumor virus: comparison of mammary tumor virus with the agent found in C3Hf/Crgl mice.
    Blair PB; Weiss DW
    J Natl Cancer Inst; 1966 Mar; 36(3):423-9. PubMed ID: 18630318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal anti-MM46 antibody:ricin A chain conjugate: in vitro and in vivo antitumor activity.
    Seto M; Umemoto N; Saito M; Masuho Y; Hara T; Takahashi T
    Cancer Res; 1982 Dec; 42(12):5209-15. PubMed ID: 6814753
    [No Abstract]   [Full Text] [Related]  

  • 29. Suppression by cytosine arabinoside of serum-blocking factors of cell-mediated immunity to syngeneic transplants of mouse mammary tumors.
    Heppner GH; Calabresi P
    J Natl Cancer Inst; 1972 Apr; 48(4):1161-7. PubMed ID: 5023677
    [No Abstract]   [Full Text] [Related]  

  • 30. Multiple genetic factors in the MHC and predominant role of D-end in the resistance against C3H-MTV-induced mammary tumors.
    Dux A
    Transplant Proc; 1983 Dec; 15(4):2101-3. PubMed ID: 6324428
    [No Abstract]   [Full Text] [Related]  

  • 31. Analysis of lymphoid cells responding to virus- and tumor-associated antigens in spleens of syngeneic mouse mammary tumor systems with low and high oncogenic potentials.
    Lopez DM; Paul RD
    J Natl Cancer Inst; 1982 Dec; 69(6):1403-9. PubMed ID: 6292565
    [No Abstract]   [Full Text] [Related]  

  • 32. Occurrence of shared nonviral tumor-associated transplantation-type antigens among C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1984 May; 44(5):1876-9. PubMed ID: 6201265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bias in observable cancer age and life-time of mice subject to spontaneous mammary carcinomas.
    Faulkner JE; McHugh RB
    Biometrics; 1972 Jun; 28(2):489-98. PubMed ID: 5037866
    [No Abstract]   [Full Text] [Related]  

  • 34. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma.
    Sloots A; Mastini C; Rohrbach F; Weth R; Curcio C; Burkhardt U; Jäger E; Forni G; Cavallo F; Wels WS
    Clin Cancer Res; 2008 Nov; 14(21):6933-43. PubMed ID: 18980988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic and in situ natural killer activity in transplanted and spontaneous mammary tumors in C3H/HeN mice.
    Gerson JM; Tagliabue A; Herberman RB
    J Reticuloendothel Soc; 1981 Jan; 29(1):15-21. PubMed ID: 7205815
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumor-associated antigens produced by mouse mammary tumor cells in artificial capillary culture.
    Hager JC; Spiegelman S; Ramanarayanan M; Bausch J; Galletti PM; Calabresi P
    J Natl Cancer Inst; 1982 Dec; 69(6):1359-66. PubMed ID: 6958911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Changes in the immune status as a function of age and the appearance of spontaneous mammary tumors in C3H/Bi mice].
    Dufer J; Benoist H; Bouchet C; Desplaces A; Saracino RT
    Bull Cancer; 1982; 69(2):143-8. PubMed ID: 7126886
    [No Abstract]   [Full Text] [Related]  

  • 38. Evolution of cell-mediated immunity in mice bearing tumors produced by a mammary carcinoma cell line. Influence of tumor growth, surgical removal, and treatment with irradiated tumor cells.
    Le François D; Youn JK; Belehradek J; Barski G
    J Natl Cancer Inst; 1971 May; 46(5):981-7. PubMed ID: 5157849
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
    Buessow SC; Paul RD; Lopez DM
    J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
    Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y
    Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.